TY  - JOUR 
AU  - Bello López, José Luis
PY  - 2014
SN  - 2352-3026
UR  - http://hdl.handle.net/20.500.11940/6312
LA  - eng
TI  - First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial
DO  - 10.1016/S2352-3026(14)00021-0
M2  - e104
VL  - 1
ER  -